Down-regulation of TRIP6 expression induces actin cytoskeleton rearrangements in human carcinoma cell lines

Molekulyarnaya Biologiya

Volumn 39, Issue 5, 2005, Pages 905-909

  Guryanova, O A ^a,b   Sablina, A A ^b   Chumakov, P M ^b,c   Frolova, E I ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b LERNER RESEARCH INSTITUTE   (United States)

^c ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

Actin cytoskeleton; Cell contacts; Cell migration; Focal contacts; RNA interferention; TRIP6

Indexed keywords

ACTIN; HOMEODOMAIN PROTEIN; PROTEIN TRIP6; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UVOMORULIN; CYTOSKELETON PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; THYROID HORMONE RECEPTOR INTERACTING PROTEIN; THYROID-HORMONE-RECEPTOR INTERACTING PROTEIN;

ARTICLE; CARCINOMA CELL; CELL ADHESION; CELL CONTACT; CELL LINE; CELL MIGRATION; CYTOSKELETON; DOWN REGULATION; HUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; CARCINOMA; CELL MOTION; DRUG ANTAGONISM; GENETICS; METABOLISM; MICROFILAMENT; PHYSIOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

ACTINS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETAL PROTEINS; DOWN-REGULATION; HUMANS; MICROFILAMENTS; RNA INTERFERENCE; TRANSCRIPTION FACTORS;

EID: 33644649468     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Alberts B., Johnson A., Levis J., Raff M., Roberts K., Walter P. 2002. Molecular Biology of the Cell. N.Y.: Garland Publishing.
2. Kadrmas J.L., Beckerle M.C. 2004. The LIM domain: from the cytoskeleton to the nucleus. Nat. Rev. Mol. Cell Biol. 5, 920-931.
3. Dawid I.B., Breen J.J., Toyama R. 1998. LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet. 14, 156-162.
4. Wang Y., Gilmore T.D. 2001. LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains. Biochim. Biophys. Acta. 1538, 260-272.
5. Yi J., Beckerle M.C. 1998. The human TRIP6 gene encodes a LIM domain protein and maps to chromosome 7q22, a region associated with tumorigenesis. Genomics. 49, 314-316.
6. Murthy K.K., Clark K., Fortin Y., Shen S.-H., Banville D. 1999. ZRP-1, a zyxin related protein, interacts with the second PDZ domain of the cytosolic protein tyrosine phosphatase hPTP1E. J. Biol. Chem. 274, 20679-20687.
7. Lee J.W., Choi H.-S., Gyuris J., Brent R., Moore D.D. 1995. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Endocrinology. 9, 243-254.
8. Koedood Zhao M., Wang Y., Murthy K., Yi J., Beckerle M.C., Gilmore T.D. 1999. LIM domain-containing protein Trip6 can act as a coactivator for the v-Rel transcription factor. Gene Expr. 8, 207-217.
9. Cuppen E., van Ham M., Wansink D.G., de Leeuw A., Wieringa B., Hendriks W. 2000. The zyxin-related protein TRIP6 interacts with PDZ motif in the adaptor protein RIL and the protein tyrosine phosphatase PTP-BL. Eur. J. Cell Biol. 79, 283-293.
10. Erdmann K.S. 2003. The protein tyrosine phosphatase PTP-Basophil/ Basophil-like: Interacting proteins and molecular functions. Eur. J. Biochem. 270, 4789-4798.
11. Bashirova A.A., Markelov M.L., Shlykova T.V., Levshenkova E.V., Alibaeva R.A., Frolova E.I. 1998. The human RIL gene: mapping to human chromosome 5q31.1, genomic organization and alternative transcripts. Gene. 210, 239-245.
12. Cas family of signal transducers. J. Biol. Chem. 277, 9580-9589.
13. Kassel O., Schneider S., Heilbock C, Litfin M., Göttlicher M., Herrlich P. 2004. A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-κB-regulated promoters. Genes Dev. 18, 2518-2528.
14. Li L., Bin L.H., Liu Y., Chen D., Zhai Z., Shu H.B. 2005. TRIP6 is RIP2-associated common signaling component of multiple NF-κB activation pathways. J. Cell Sci. 118, 555-563.
15. Dykxhoorn D.M., Novina C.D., Sharp P.A. 2003. Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol. 4, 457-467.
16. Thiery J.P. 2002. Epithelial-mesenchymal transitions in tumor progression. Nat. Rev. Cancer. 2, 442-454.
17. Malliri A., Symons M., Hennigan R.F., Hurlstone A.F.L., Lamb R.F., Wheeler T., Ozanne B.W. 1998. The transcription factor AP-1 is required for EGF-induced activation of Rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells. J. Cell Biol. 143, 1087-1099.
18. Vallenius T., Scharm B., Vesikansa A., Luukko K., Schäfer R., Mäkelä T. 2004. The PDZ-LIM protein RIL modulates actin stress fiber turnover and enhances the association of α-actinin with F-actin. Exp. Cell Res. 293, 117-128.
19. Bouton A.H., Riggins R.B., Bruce-Staskal P.J. 2001. Functions of the adapter protein Cas: signal convergence and determination of cellular responses. Oncogene. 20, 6448-6458.
20. Erdmann K.S., Kuhlmann J., Lessmann V., Herrmann L., Eulenburg V., Muller O., Heumann R. 2000. The Adenomatous Polyposis Coli-protein (APC) interacts with the protein tyrosine phosphatase PTP-BL via an alternatively spliced PDZ domain. Oncogene. 19, 3894-3901.
21. Nelson W.J., Nusse R. 2004. Convergence of Wnt, β-catenin, and cadherin pathways. Science. 303, 1483-1487.
22. Yun M.-S., Kim S.-E., Jeon S.H., Lee J.-S., Choi K.-Y. 2005. Both ERK and Wnt/β-catenin pathways are involved in Wnt3a-induced proliferation. J. Cell Sci. 118, 313-322.
23. Sansom O.J., Reed K.R., Hayes A.J., Ireland H., Brinkmann H., Newton I.P., Batlle E., Simon-Assmann P., Clevers H., Nathke I.S., Clarke A.R., Winton D.J. 2004. Loss of Ape in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 18, 1385-1390.